Advanced AI models are ineffective in clinical settings without a robust data layer. Ambience had to solve fundamental problems like pulling messy context from inconsistent EHRs and preserving 'decision traces,' which are often destroyed by existing systems with mutable data structures.

Numerous venture-backed healthcare AI models struggle to achieve clinical adoption because they fail to solve distinct, practical problems. Medical innovators succeed by working backward from operational hurdles, such as using focused algorithms to immediately score dense breast tissue and triage patients on-site.

Applying AI to a fundamentally flawed system like U.S. healthcare billing doesn't fix it. Instead, it creates an arms race where insurer bots fight hospital bots over claims. This only increases complexity and benefits the technology providers, while the core problems remain unsolved.

Patients and providers increasingly use AI agents for advice, but these tools often fail because their underlying data lacks semantic context. To provide relevant, personalized responses instead of generic ones, data must be enriched to understand the patient's specific situation and journey.

The friction of navigating insurance and pharmacies is so high that chronic disease patients often give up, skipping tests or medications and directly worsening their health. AI can automate these tedious tasks, removing the barriers that lead to non-compliance and poor health outcomes.

Cleveland Clinic's sepsis AI reduced mortality by 41% but still missed cases that nurses spotted through intuitive cues like smell or skin tone. This reveals that even the best AI struggles with the 'last mile' where human expertise operates beyond quantifiable data and predictable patterns.

Singhal says medical care bundles diagnosis, physical exams, empathy, and legal liability that AI cannot fully provide. Even with pre-visit research, the human visit remains necessary for history-taking, physical interaction, comfort, and a second check. That limits AI's role to support rather than replace care.

Chronic disease patients face a cascade of interconnected problems: pre-authorizations, pharmacy stockouts, and incomprehensible insurance rules. AI's potential lies in acting as an intelligent agent to navigate this complex, fragmented system on behalf of the patient, reducing waste and improving outcomes.

Roloff agrees that AI in medicine is constrained less by models or compute than by access to sensitive data. He says privacy technology is ahead of community acceptance; secure inference through commercial trusted execution environments is emerging, but training large foundational models on patient data remains the 'golden apple' still being pursued.